Martellucci J, Rossi G, Corsale I, Carrieri P, D'Elia M, Giani I
General, Emergency and Mini-invasive Surgery, Careggi University Hospital, Largo Brambilla 3, 50134, Florence, Italy.
General Surgery Unit, Prato Hospital, Prato, Italy.
Updates Surg. 2017 Dec;69(4):499-503. doi: 10.1007/s13304-017-0450-z. Epub 2017 Apr 22.
Myoxinol is a complex of oligopeptides obtained from the seeds of Hibiscus esculentus used in cosmetic as natural alternative to botulin toxin. The aim of the study was to evaluate the safety and effectiveness of local myoxinol for the treatment of acute anal fissure. All the consecutive patients with acute fissure treated from January to June 2014 underwent 30 days of topical treatment (twice/day) with a mioxinol based ointment. Pain, symptomatic relief, fissure healing and re-epithelization, 1-year recurrence rate, subjective satisfaction and need for further treatments were evaluated. During the study period 157 patients were eligible for data analysis (91 males: 58%; mean age 38 years: range 17-83). Median anal pain score was 7.1 pre-treatment and 1.7 and 0.9 after 30 days and 12 months from treatment, respectively (p: 0.0001). After the treatment period complete healing was achieved in 103 patients (65.5%), relevant improvement in 31 (20%) and no improvement in 21 patients (13.5%). Overall efficacy rate was 85.5%. A significant difference was reported considering patients with pre-treatment VAS between 1-5 and 6-10 (p: 0.004). Twenty-nine patients (18.5%) required further treatments. Hydrolyzed Hibiscus esculentus extract was proven to be an effective and well-tolerated topical treatment for acute fissure, with a high healing rate, a significant reduction of pain and a low 1-year recurrence rate.
肌醇六磷酸酶是一种从黄秋葵种子中提取的寡肽复合物,在化妆品中用作肉毒杆菌毒素的天然替代品。本研究的目的是评估局部使用肌醇六磷酸酶治疗急性肛裂的安全性和有效性。2014年1月至6月期间,所有连续接受治疗的急性肛裂患者均接受了30天的局部治疗(每天两次),使用基于肌醇六磷酸酶的软膏。评估了疼痛、症状缓解、肛裂愈合和再上皮化、1年复发率、主观满意度以及进一步治疗的需求。在研究期间,157例患者符合数据分析条件(91例男性:58%;平均年龄38岁:范围17 - 83岁)。治疗前肛门疼痛评分中位数为7.1,治疗30天后为1.7,治疗12个月后为0.9(p:0.0001)。治疗期结束后,103例患者(65.5%)实现完全愈合,31例(20%)有显著改善,21例患者(13.5%)无改善。总有效率为85.5%。在考虑治疗前VAS为1 - 5和6 - 10的患者时,报告有显著差异(p:0.004)。29例患者(18.5%)需要进一步治疗。水解黄秋葵提取物被证明是一种治疗急性肛裂有效且耐受性良好的局部治疗方法,愈合率高,疼痛显著减轻,1年复发率低。